Orchid Chemicals & Pharmaceuticals, a leading Chennai-based pharma major, has revealed that it has got its abbreviated new drug application sanctioned form US Food and Drug Administration to sell anti-epilepsy drug Divalproex sodium tablets in the US.

The company has been allowed to market the drug in the strengths of 125 mg, 250 mg and 500 mg.